Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users
Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore;...
Gespeichert in:
Veröffentlicht in: | AIDS and behavior 2005-09, Vol.9 (3), p.301-309 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 309 |
---|---|
container_issue | 3 |
container_start_page | 301 |
container_title | AIDS and behavior |
container_volume | 9 |
creator | Golub, Elizabeth T Purvis, Lisa A Sapun, Marcella Safaeian, Mahboobeh Beyrer, Chris Vlahov, David Strathdee, Steffanie A |
description | Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore; semi-annual visits include interviews and HIV serology. Questionnaires regarding WTP were administered in 1993-1994 and again in 2001-2002. Logistic regression was conducted to identify correlates of WTP. Wave 1 of the survey included 440 participants; Wave 2 included 582 participants (189 participated in both waves). WTP increased modestly over time (83.4 vs. 86.3%; p = 0.16). Monetary incentives were the strongest predictor of WTP (adjOR = 2.73; 95% CI: 1.72-4.35). High expectations of HIV treatment effectiveness did not predict WTP. In this cohort, WTP remained strong and modestly increased over the study period. These results should be considered in the planning of sampling and retention strategies for future vaccine trials. |
doi_str_mv | 10.1007/s10461-005-9004-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_57202552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>923938571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-4e817ebe7daee77e3b5842ad0502c5f77593bcf7fc48e6340e98d2c49d982e93</originalsourceid><addsrcrecordid>eNqFkU1r3DAQhkVJadK0P6CXIHLoTe1Isr6OYUmbwEIvoVehlceuFq-8keyE_vva7EKhl55mYJ73heEh5BOHLxzAfK0cGs0ZgGIOoGHyDbniykgmhWoulh0cMMO1uiTva90DgNPGvSOXXIO1UusrEje_Qu6x0pTpaxqGlPuMtdJppMdQphTTMUy4Xh8ef9KXEGPKSKeSwlBpOIy5Xw8sYx-m9LKCe4xTGjNty9zTuWKpH8jbbsHx43lek6dv90-bB7b98f1xc7dlUVo7sQYtN7hD0wZEY1DulG1EaEGBiKozRjm5i53pYmNRywbQ2VbExrXOCnTymnw-1R7L-Dxjnfwh1YjDEDKOc_XKCBBKif-C3AhutIAFvP0H3I9zycsPXnDOnQYhF4ifoFjGWgt2_ljSIZTfnoNfNfmTJr9o8qsmv2ZuzsXz7oDt38TZi_wDsaONVg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211196023</pqid></control><display><type>article</type><title>Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users</title><source>MEDLINE</source><source>Sociological Abstracts</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>SpringerLink Journals (MCLS)</source><creator>Golub, Elizabeth T ; Purvis, Lisa A ; Sapun, Marcella ; Safaeian, Mahboobeh ; Beyrer, Chris ; Vlahov, David ; Strathdee, Steffanie A</creator><creatorcontrib>Golub, Elizabeth T ; Purvis, Lisa A ; Sapun, Marcella ; Safaeian, Mahboobeh ; Beyrer, Chris ; Vlahov, David ; Strathdee, Steffanie A</creatorcontrib><description>Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore; semi-annual visits include interviews and HIV serology. Questionnaires regarding WTP were administered in 1993-1994 and again in 2001-2002. Logistic regression was conducted to identify correlates of WTP. Wave 1 of the survey included 440 participants; Wave 2 included 582 participants (189 participated in both waves). WTP increased modestly over time (83.4 vs. 86.3%; p = 0.16). Monetary incentives were the strongest predictor of WTP (adjOR = 2.73; 95% CI: 1.72-4.35). High expectations of HIV treatment effectiveness did not predict WTP. In this cohort, WTP remained strong and modestly increased over the study period. These results should be considered in the planning of sampling and retention strategies for future vaccine trials.</description><identifier>ISSN: 1090-7165</identifier><identifier>EISSN: 1573-3254</identifier><identifier>DOI: 10.1007/s10461-005-9004-3</identifier><identifier>PMID: 16088366</identifier><identifier>CODEN: AIBEFC</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Acquired immune deficiency syndrome ; Adult ; AIDS ; AIDS Serodiagnosis ; AIDS Vaccines - administration & dosage ; Clinical trials ; Clinical Trials as Topic ; Drug abusers ; Epidemiology ; Female ; Financial incentives ; HIV ; HIV Infections - diagnosis ; HIV Infections - prevention & control ; Human immunodeficiency virus ; Humans ; Injection ; Interviews as Topic ; Logistic Models ; Male ; Patient Participation - psychology ; Prevention ; Prospective Studies ; Public health ; Questionnaires ; Substance Abuse, Intravenous - complications ; Surveys and Questionnaires ; Vaccines ; Willingness</subject><ispartof>AIDS and behavior, 2005-09, Vol.9 (3), p.301-309</ispartof><rights>Springer Science+Business Media, Inc. 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-4e817ebe7daee77e3b5842ad0502c5f77593bcf7fc48e6340e98d2c49d982e93</citedby><cites>FETCH-LOGICAL-c388t-4e817ebe7daee77e3b5842ad0502c5f77593bcf7fc48e6340e98d2c49d982e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27344,27924,27925,31000,33774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16088366$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Golub, Elizabeth T</creatorcontrib><creatorcontrib>Purvis, Lisa A</creatorcontrib><creatorcontrib>Sapun, Marcella</creatorcontrib><creatorcontrib>Safaeian, Mahboobeh</creatorcontrib><creatorcontrib>Beyrer, Chris</creatorcontrib><creatorcontrib>Vlahov, David</creatorcontrib><creatorcontrib>Strathdee, Steffanie A</creatorcontrib><title>Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users</title><title>AIDS and behavior</title><addtitle>AIDS Behav</addtitle><description>Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore; semi-annual visits include interviews and HIV serology. Questionnaires regarding WTP were administered in 1993-1994 and again in 2001-2002. Logistic regression was conducted to identify correlates of WTP. Wave 1 of the survey included 440 participants; Wave 2 included 582 participants (189 participated in both waves). WTP increased modestly over time (83.4 vs. 86.3%; p = 0.16). Monetary incentives were the strongest predictor of WTP (adjOR = 2.73; 95% CI: 1.72-4.35). High expectations of HIV treatment effectiveness did not predict WTP. In this cohort, WTP remained strong and modestly increased over the study period. These results should be considered in the planning of sampling and retention strategies for future vaccine trials.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adult</subject><subject>AIDS</subject><subject>AIDS Serodiagnosis</subject><subject>AIDS Vaccines - administration & dosage</subject><subject>Clinical trials</subject><subject>Clinical Trials as Topic</subject><subject>Drug abusers</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Financial incentives</subject><subject>HIV</subject><subject>HIV Infections - diagnosis</subject><subject>HIV Infections - prevention & control</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Injection</subject><subject>Interviews as Topic</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Patient Participation - psychology</subject><subject>Prevention</subject><subject>Prospective Studies</subject><subject>Public health</subject><subject>Questionnaires</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Surveys and Questionnaires</subject><subject>Vaccines</subject><subject>Willingness</subject><issn>1090-7165</issn><issn>1573-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>BHHNA</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><sourceid>7QJ</sourceid><recordid>eNqFkU1r3DAQhkVJadK0P6CXIHLoTe1Isr6OYUmbwEIvoVehlceuFq-8keyE_vva7EKhl55mYJ73heEh5BOHLxzAfK0cGs0ZgGIOoGHyDbniykgmhWoulh0cMMO1uiTva90DgNPGvSOXXIO1UusrEje_Qu6x0pTpaxqGlPuMtdJppMdQphTTMUy4Xh8ef9KXEGPKSKeSwlBpOIy5Xw8sYx-m9LKCe4xTGjNty9zTuWKpH8jbbsHx43lek6dv90-bB7b98f1xc7dlUVo7sQYtN7hD0wZEY1DulG1EaEGBiKozRjm5i53pYmNRywbQ2VbExrXOCnTymnw-1R7L-Dxjnfwh1YjDEDKOc_XKCBBKif-C3AhutIAFvP0H3I9zycsPXnDOnQYhF4ifoFjGWgt2_ljSIZTfnoNfNfmTJr9o8qsmv2ZuzsXz7oDt38TZi_wDsaONVg</recordid><startdate>200509</startdate><enddate>200509</enddate><creator>Golub, Elizabeth T</creator><creator>Purvis, Lisa A</creator><creator>Sapun, Marcella</creator><creator>Safaeian, Mahboobeh</creator><creator>Beyrer, Chris</creator><creator>Vlahov, David</creator><creator>Strathdee, Steffanie A</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7T2</scope><scope>7U3</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AM</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGRYB</scope><scope>BHHNA</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HEHIP</scope><scope>K7.</scope><scope>K9.</scope><scope>KB0</scope><scope>M0O</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7QJ</scope></search><sort><creationdate>200509</creationdate><title>Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users</title><author>Golub, Elizabeth T ; Purvis, Lisa A ; Sapun, Marcella ; Safaeian, Mahboobeh ; Beyrer, Chris ; Vlahov, David ; Strathdee, Steffanie A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-4e817ebe7daee77e3b5842ad0502c5f77593bcf7fc48e6340e98d2c49d982e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adult</topic><topic>AIDS</topic><topic>AIDS Serodiagnosis</topic><topic>AIDS Vaccines - administration & dosage</topic><topic>Clinical trials</topic><topic>Clinical Trials as Topic</topic><topic>Drug abusers</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Financial incentives</topic><topic>HIV</topic><topic>HIV Infections - diagnosis</topic><topic>HIV Infections - prevention & control</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Injection</topic><topic>Interviews as Topic</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Patient Participation - psychology</topic><topic>Prevention</topic><topic>Prospective Studies</topic><topic>Public health</topic><topic>Questionnaires</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Surveys and Questionnaires</topic><topic>Vaccines</topic><topic>Willingness</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Golub, Elizabeth T</creatorcontrib><creatorcontrib>Purvis, Lisa A</creatorcontrib><creatorcontrib>Sapun, Marcella</creatorcontrib><creatorcontrib>Safaeian, Mahboobeh</creatorcontrib><creatorcontrib>Beyrer, Chris</creatorcontrib><creatorcontrib>Vlahov, David</creatorcontrib><creatorcontrib>Strathdee, Steffanie A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Social Services Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Criminal Justice Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Criminology Collection</collection><collection>Sociological Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Sociology Collection</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Criminal Justice Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest research library</collection><collection>Sociology Database (ProQuest)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><jtitle>AIDS and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Golub, Elizabeth T</au><au>Purvis, Lisa A</au><au>Sapun, Marcella</au><au>Safaeian, Mahboobeh</au><au>Beyrer, Chris</au><au>Vlahov, David</au><au>Strathdee, Steffanie A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users</atitle><jtitle>AIDS and behavior</jtitle><addtitle>AIDS Behav</addtitle><date>2005-09</date><risdate>2005</risdate><volume>9</volume><issue>3</issue><spage>301</spage><epage>309</epage><pages>301-309</pages><issn>1090-7165</issn><eissn>1573-3254</eissn><coden>AIBEFC</coden><abstract>Injection drug users (IDUs) represent an important risk group for HIV infection. We assessed correlates of IDUs' willingness to participate (WTP) in HIV vaccine trials, and examined temporal changes in WTP. Participants were enrolled in ALIVE, a prospective study of HIV among IDUs in Baltimore; semi-annual visits include interviews and HIV serology. Questionnaires regarding WTP were administered in 1993-1994 and again in 2001-2002. Logistic regression was conducted to identify correlates of WTP. Wave 1 of the survey included 440 participants; Wave 2 included 582 participants (189 participated in both waves). WTP increased modestly over time (83.4 vs. 86.3%; p = 0.16). Monetary incentives were the strongest predictor of WTP (adjOR = 2.73; 95% CI: 1.72-4.35). High expectations of HIV treatment effectiveness did not predict WTP. In this cohort, WTP remained strong and modestly increased over the study period. These results should be considered in the planning of sampling and retention strategies for future vaccine trials.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>16088366</pmid><doi>10.1007/s10461-005-9004-3</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1090-7165 |
ispartof | AIDS and behavior, 2005-09, Vol.9 (3), p.301-309 |
issn | 1090-7165 1573-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_57202552 |
source | MEDLINE; Sociological Abstracts; Applied Social Sciences Index & Abstracts (ASSIA); SpringerLink Journals (MCLS) |
subjects | Acquired immune deficiency syndrome Adult AIDS AIDS Serodiagnosis AIDS Vaccines - administration & dosage Clinical trials Clinical Trials as Topic Drug abusers Epidemiology Female Financial incentives HIV HIV Infections - diagnosis HIV Infections - prevention & control Human immunodeficiency virus Humans Injection Interviews as Topic Logistic Models Male Patient Participation - psychology Prevention Prospective Studies Public health Questionnaires Substance Abuse, Intravenous - complications Surveys and Questionnaires Vaccines Willingness |
title | Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A02%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20willingness%20to%20participate%20in%20HIV%20vaccine%20trials%20among%20HIV-negative%20injection%20drug%20users&rft.jtitle=AIDS%20and%20behavior&rft.au=Golub,%20Elizabeth%20T&rft.date=2005-09&rft.volume=9&rft.issue=3&rft.spage=301&rft.epage=309&rft.pages=301-309&rft.issn=1090-7165&rft.eissn=1573-3254&rft.coden=AIBEFC&rft_id=info:doi/10.1007/s10461-005-9004-3&rft_dat=%3Cproquest_cross%3E923938571%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211196023&rft_id=info:pmid/16088366&rfr_iscdi=true |